hours, appearance of inhibitory zones were observ- supplemented with fortimicin AO.These latter were assumed to be blocked at the steps before sms4/5, corresponding to fms4/5 converting step from FU10 to AOin M. olivasterospora. These mutants were designated as "Group I" mutants. On supplementing with fortimicin KR, 18 out of the remaining 21 mutants were restored to antibiotic production.
They were presumably blocked at the steps between sms6 (corresponding to fms6; AO to KL1) and smsl 1 (corresponding to fmsl 1; epimerization from fortimicin KHto KR). These mutants are designated as "Group II" mutants. As converting activity fortimicin B to A was detected in washed mycelia of the other three mutants, they correspond to mutants blocked at the step ofsmsl2 (corresponding to fmsl2; KRto B). These mutants were designated as "Group III" mutants. Thus the 48 nonproducing mutants could be classified into four groups as shown in Fig. 1 .
Group I mutants could be restored to production by supplementing with fortimicin AO; in spite of the fact that S. sannanensis could not convert fortimicin KHto KR(epimerization of 2-hydroxy group of fortamine moiety; the step of fmsll) at the downstream step in fortimicin A biosynthesis5).
This observation suggests that dehydroxylation of the 2-hydroxy group occurs at the step between sms6 and smsl l in S. sannanensis.
Wefound some mutants which lost their ability to sporulate among the leaky mutants. They might be defect in a factor regulating both secondary metabolism and differentiation like A-factor of Streptomyces griseus6). A low molecular weight 291 factor, degnated as S-factor required for the fortimicin Aproduction was found in M. olivasterospora (Kase; personal communication). We are concurrently analyzing the relationship of these pleiotropic mutants and S-factor.
